Back to mobile site

More on IQV

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+8.2% Growth)
- Ratings (8.0 Score)
- Holders

Upcoming Events

- Earnings (7/28/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

IQVIA Holdings (NY:IQV)
Delayed: 170.30 +2.49 (1.48%)
Prev. Close $167.81  
Open$169.95 
52 Wk High$ 
52 Wk Low$ 
Day High$172.12 
Day Low$168.75 
P/E N/A  
EPS$ 
Volume156,180 

Friends, Peers and Foes (?): CRL, FHTX, MRNA, SANA, MEDP (more...)

Jun 17, 2026 08:47 AM Morgan Stanley favors Charles River Over IQVIA in CRO sector reset
Jun 17, 2026 06:29 AM Morgan Stanley Downgrades IQVIA Holdings (IQV) to Equalweight
Jun 17, 2026 06:29 AM Morgan Stanley Upgrades Charles River Labs (CRL) to Overweight, 'strong uptick in biopharma funding beginning to transition into RFPs and bookings'
Jun 15, 2026 09:00 AM Wiley and IQVIA Release Cross-Sector Report on AI’s Promise and Pressure Points Across Healthcare Value Chain
Jun 11, 2026 04:47 PM Form 8-K IQVIA HOLDINGS INC. For: Jun 11
Jun 5, 2026 08:59 AM Morgan Stanley tracks prescription trends for US neurology drugs
Jun 5, 2026 08:49 AM RBC Capital: 'Miebo remains the second-largest Rx DED drug in the US with 22.8% market share'
Jun 4, 2026 05:08 PM Form 8-K IQVIA HOLDINGS INC. For: Jun 04
Jun 4, 2026 10:51 AM IQVIA prices €950 million senior notes due 2033
Jun 4, 2026 10:51 AM IQVIA Announces Pricing of Senior Notes
View All Articles

Entities mentioned with IQV

View All Entities